PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$72.56 USD
-0.07 (-0.10%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $72.61 +0.05 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 58 | 27 | 32 | 95 | 28 |
Receivables | 167 | 139 | 115 | 151 | 149 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 162 | 120 | 115 | 116 | 120 |
Other Current Assets | 4 | 6 | 8 | 4 | 5 |
Total Current Assets | 392 | 293 | 270 | 366 | 301 |
Net Property & Equipment | 70 | 71 | 70 | 56 | 51 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2,869 | 3,276 | 3,054 | 3,055 | 3,086 |
Deposits & Other Assets | 3 | 3 | 3 | 3 | 3 |
Total Assets | 3,354 | 3,671 | 3,429 | 3,514 | 3,441 |
Liabilities & Shareholders Equity | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 63 | 56 | 46 | 62 | 57 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 3 | 3 | 3 | 1 | 0 |
Accrued Expenses | 88 | 79 | 68 | 81 | 70 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 161 | 143 | 122 | 150 | 127 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 380 | 445 | 434 | 408 | 400 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,346 | 1,477 | 1,480 | 1,730 | 1,799 |
Non-Current Capital Leases | 2 | 5 | 7 | 5 | 0 |
Other Non-Current Liabilities | 8 | 7 | 9 | 25 | 20 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,907 | 2,093 | 2,071 | 2,343 | 2,345 |
Shareholders Equity | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 535 | 516 | 500 | 488 | 479 |
Retained Earnings | 1,132 | 1,214 | 1,009 | 844 | 702 |
Other Equity | -32 | -19 | -20 | -44 | -26 |
Treasury Stock | 189 | 134 | 131 | 118 | 60 |
Total Shareholder's Equity | 1,447 | 1,578 | 1,358 | 1,171 | 1,096 |
Total Liabilities & Shareholder's Equity | 3,354 | 3,671 | 3,429 | 3,514 | 3,441 |
Total Common Equity | 1,447 | 1,578 | 1,358 | 1,171 | 1,096 |
Shares Outstanding | 49.60 | 50.20 | 49.80 | 50.20 | 51.80 |
Book Value Per Share | 29.18 | 31.43 | 27.28 | 23.33 | 21.16 |
Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.
All items in Millions except Per Share data.
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 64 | 60 | 55 | 58 | 86 |
Receivables | 174 | 158 | 158 | 167 | 157 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 149 | 161 | 170 | 162 | 159 |
Other Current Assets | 7 | 8 | 9 | 4 | 7 |
Total Current Assets | 394 | 388 | 392 | 392 | 409 |
Net Property & Equipment | 70 | 71 | 70 | 70 | 70 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2,856 | 2,855 | 2,864 | 2,869 | 3,247 |
Deposits & Other Assets | 6 | 4 | 3 | 3 | 3 |
Total Assets | 3,340 | 3,333 | 3,346 | 3,354 | 3,750 |
Liabilities & Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 39 | 44 | 58 | 63 | 64 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 2 | 3 | 3 | 3 | 3 |
Accrued Expenses | 80 | 76 | 80 | 88 | 86 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 127 | 130 | 147 | 161 | 160 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 397 | 388 | 384 | 380 | 456 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,199 | 1,263 | 1,317 | 1,346 | 1,424 |
Non-Current Capital Leases | 0 | 0 | 1 | 2 | 2 |
Other Non-Current Liabilities | 9 | 8 | 8 | 9 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,739 | 1,797 | 1,865 | 1,907 | 2,063 |
Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 556 | 552 | 547 | 535 | 533 |
Retained Earnings | 1,292 | 1,239 | 1,185 | 1,132 | 1,372 |
Other Equity | -29 | -36 | -32 | -32 | -29 |
Treasury Stock | 220 | 220 | 220 | 189 | 189 |
Total Shareholder's Equity | 1,601 | 1,536 | 1,480 | 1,447 | 1,687 |
Total Liabilities & Shareholder's Equity | 3,340 | 3,333 | 3,346 | 3,354 | 3,750 |
Total Common Equity | 1,601 | 1,536 | 1,480 | 1,447 | 1,687 |
Shares Outstanding | 49.60 | 49.60 | 49.50 | 49.60 | 49.60 |
Book Value Per Share | 32.27 | 30.97 | 29.91 | 29.18 | 34.01 |